202 related articles for article (PubMed ID: 9209197)
21. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.
Hasenclever D; Diehl V
N Engl J Med; 1998 Nov; 339(21):1506-14. PubMed ID: 9819449
[TBL] [Abstract][Full Text] [Related]
22. Serum IL-13 levels at diagnosis and remission in children with malignant lymphoma.
Özyörük D; Yavuz G; Dinçaslan H; Cabı-Unal E; Taçyıldız N; Karataş D; Doğu F; İkincioğulları A
Turk J Pediatr; 2016; 58(3):246-253. PubMed ID: 28266188
[TBL] [Abstract][Full Text] [Related]
23. Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma.
Guney N; Soydinc HO; Basaran M; Bavbek S; Derin D; Camlica H; Yasasever V; Topuz E
Asian Pac J Cancer Prev; 2009; 10(4):669-74. PubMed ID: 19827892
[TBL] [Abstract][Full Text] [Related]
24. [Differential diagnostic and prognostic value of serum cytokines (soluble CD30, soluble interleukin-2 receptor, interleukin-10 and interleukin-6) in Hodgkin's disease and lymphosarcomas].
Iaguzhinskaia OE; Lazarev IE; Nikitin EA; Samoĭlova RS; Loginova IV; Gemdzhan EG; Novikov VA; Mamiliaeva ZKh; Pivnik AV
Ter Arkh; 2001; 73(4):45-51. PubMed ID: 11494447
[TBL] [Abstract][Full Text] [Related]
25. Serum IL-10 and IL-6 levels at diagnosis as independent predictors of outcome in non-Hodgkin's lymphoma.
el-Far M; Fouda M; Yahya R; el-Baz H
J Physiol Biochem; 2004 Dec; 60(4):253-8. PubMed ID: 15957243
[TBL] [Abstract][Full Text] [Related]
26. Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy.
Visco C; Vassilakopoulos TP; Kliche KO; Nadali G; Viviani S; Bonfante V; Medeiros LJ; Notti P; Rassidakis GZ; Peethambaram P; Wilder R; Witzig T; Gianni M; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
Leuk Lymphoma; 2004 Oct; 45(10):2085-92. PubMed ID: 15370254
[TBL] [Abstract][Full Text] [Related]
27. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
28. Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: correlation with disease activity and other prognostic parameters.
Nachbaur DM; Herold M; Maneschg A; Huber H
Ann Hematol; 1991; 62(2-3):54-8. PubMed ID: 2031968
[TBL] [Abstract][Full Text] [Related]
29. Soluble factors levels in the initial staging of high-grade non-Hodgkin's lymphomas.
Stasi R; Conforti M; Del Poeta G; Simone MD; Coppetelli U; Tribalto M; Cantonetti M; Perrotti A; Venditti A; Papa G
Haematologica; 1992; 77(6):518-21. PubMed ID: 1289190
[TBL] [Abstract][Full Text] [Related]
30. Serum cytokine levels correlate with clinical parameters in Hodgkin's disease.
Gorschlüter M; Bohlen H; Hasenclever D; Diehl V; Tesch H
Ann Oncol; 1995 May; 6(5):477-82. PubMed ID: 7545429
[TBL] [Abstract][Full Text] [Related]
31. Pre-treatment serum levels of interleukin-10, interleukin-12 and their ratio predict response to therapy and probability of event-free and overall survival in childhood soft tissue sarcomas, Hodgkin's lymphomas and acute lymphoblastic leukemias.
Bien E; Balcerska A; Adamkiewicz-Drozynska E; Rapala M; Krawczyk M; Stepinski J
Clin Biochem; 2009 Jul; 42(10-11):1144-57. PubMed ID: 19376105
[TBL] [Abstract][Full Text] [Related]
32. Serum levels of cytokines and prevalence of autoantibodies in lymphoma patients and their prognostic value.
Uskudar Teke H; Gulbas Z; Bal C
J BUON; 2014; 19(1):191-7. PubMed ID: 24659663
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 6 expression by Hodgkin/Reed-Sternberg cells is associated with the presence of 'B' symptoms and failure to achieve complete remission in patients with advanced Hodgkin's disease.
Reynolds GM; Billingham LJ; Gray LJ; Flavell JR; Najafipour S; Crocker J; Nelson P; Young LS; Murray PG
Br J Haematol; 2002 Jul; 118(1):195-201. PubMed ID: 12100148
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome.
Fayad L; Keating MJ; Reuben JM; O'Brien S; Lee BN; Lerner S; Kurzrock R
Blood; 2001 Jan; 97(1):256-63. PubMed ID: 11133769
[TBL] [Abstract][Full Text] [Related]
35. Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid.
Rubio R
Cancer; 1994 May; 73(9):2400-7. PubMed ID: 8168044
[TBL] [Abstract][Full Text] [Related]
36. [Plasma interleukin-6 and interleukin-10 levels in different subtypes of lymphoma and their clinical significance].
Wang X; Zhao HR; Gu X; Liu P; Bikmituofu H
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1360-4. PubMed ID: 21868324
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease.
Gause A; Pohl C; Tschiersch A; Da Costa L; Jung W; Diehl V; Hasenclever D; Pfreundschuh M
Blood; 1991 May; 77(9):1983-8. PubMed ID: 1850308
[TBL] [Abstract][Full Text] [Related]
38. [Diagnostic and prognostic value of interleukin-6 in malignant non-Hodgkin's lymphomas].
Serebriakov NB; Novik AA; Shamanskiĭ SV; Krivolapov IuA; Voloshin SV; D'iakova VV; Snetkova IG; Katkova IV; Zhiburt EB
Vestn Ross Akad Med Nauk; 1998; (10):32-6. PubMed ID: 9846110
[TBL] [Abstract][Full Text] [Related]
39. Correlation between clinical features and circulating levels of soluble intercellular adhesion molecule-1 in Hodgkin's disease.
Nadali G; Vinante F; Rigo A; Tecchio C; Morosato L; Zanolin E; Perona G; Chilosi M; Pizzolo G
Int J Clin Lab Res; 1995; 25(2):84-7. PubMed ID: 7663010
[TBL] [Abstract][Full Text] [Related]
40. The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease.
Molin D; Glimelius B; Sundström C; Venge P; Enblad G
Leuk Lymphoma; 2001 Jul; 42(3):457-65. PubMed ID: 11699410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
